Cargando…
Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques
The occurrence of the SARS-CoV2 infection has become a worldwide threat and the urgent need to discover therapeutic interventions remains paramount. The primary roles of the coronavirus nucleocapsid (N) protein are to interact with the viral genome and pack them into ribonucleoprotein complex. It al...
Autores principales: | Kwarteng, Alexander, Asiedu, Ebenezer, Sakyi, Samuel Amoah, Asiedu, Samuel Opoku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574726/ https://www.ncbi.nlm.nih.gov/pubmed/33254432 http://dx.doi.org/10.1016/j.biopha.2020.110914 |
Ejemplares similares
-
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
por: Kwarteng, Alexander, et al.
Publicado: (2021) -
Highlighting the Relevance of CD8(+) T Cells in Filarial Infections
por: Kwarteng, Alexander, et al.
Publicado: (2021) -
Prospects of Immunology Education and Research in Developing Countries
por: Kwarteng, Alexander, et al.
Publicado: (2021) -
In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase
por: Kwarteng, Alexander, et al.
Publicado: (2021) -
SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery
por: Royster, Austin, et al.
Publicado: (2023)